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Abstract 
Objective: To estimate the prevalence and socioeconomic characteristics of Chronic Kidney Disease (CKD) in 
first and second-degree relatives of patients on hemodialysis Method: A questionnaire was applied on 
socioeconomic conditions, lifestyle, and personal pathological background. The formula of CKD-EPI and/or 
proteinuria greater than or equal to 1+ was used to characterize CKD. Analysis using the logistic regression 
model. Results: 408 individuals were evaluated and 12% had CKD. 6.61% had a glomerular filtration rate (GFR) 
≤ 60 mL / min / 1.73 m2 and 5.39% proteinuria in the urine. The variables associated with the presence of CKD 
were age (OR = 1,60; 95% IC = 1,31-1,96), PAS (OR: 1,69; 95% IC: 1,24-2,28), PAD (OR: 1,52; 95% IC: 1,18- 
1,96) and blood glucose (OR: 2,03; 95% IC: 1,38-2,99). Conclusion: It is necessary to implement routines for 
systematic evaluation that prevent or delay the loss of renal function, in addition to measures that improve the 
pre-dialysis clinical conditions of this population.  
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1.1 INTRODUCTION 
With the aging of the population and the advent of cardiovascular diseases, many authors have considered 
chronic kidney disease (CKD) as the "millennium epidemic". Even in developed countries, CKD is a serious 
global public health problem due to its increasing morbidity and mortality, incidence and prevalence, as well as 
high economic costs to health systems (Wen et al., 2014; Saran et al., 2017). 
As a nearly asymptomatic disease in its early stages, the actual prevalence of CKD is still unknown, even in 
countries like Japan and the United States (USA) that have a robust database on the pathology (Mills et al., 2015). 
According to a meta-analysis carried out with approximately 100 studies, it is estimated that the prevalence is 
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around 15% (Hill et al., 2016). In Brazil, few studies have addressed the prevalence of CKD, especially if we 
consider those that used the criteria for defining CKD proposed by Kidney Disease Improving Global Outcomes 
(KDIGO). Data from a systematic review that used studies with different methodologies for the diagnosis of 
CKD, including self-referral, found prevalences in Brazil that ranged from 1.43% to 27.20% (Marinho, Penha, 
Silva & Galvão, 2017). 
Alarmed by the economic and health impact of CKD, many countries have turned their efforts to strategies 
that allow early diagnosis. Early diagnosis provides delayed decline in renal function, decreased need and length 
of hospital stay, reduces the initial costs of dialysis treatment, increases the likelihood of a preemptive transplant, 
improves the patient's clinical conditions before dialysis treatment, ensures permanent vascular access before 
dialysis, and decreases morbidity-mortality (Cooper et al., 2010; Lopez-Vargas, Tong, Sureshkumar, Johnson & 
Craig, 2013). 
Most studies are aimed at patients with cardiovascular diseases, diabetes, and hypertension, groups that are 
known to be at risk for CKD, however, relatives of patients with CKD also belong to the risk group, even though 
they are not so studied (Obrador, Mahdavi-Mazdeh & Collins, 2011). 
Despite the scarcity, some studies have already evaluated relatives of patients with CKD and demonstrated 
a high prevalence of the pathology (Wei et al., 2012), such as the 49.3% found by Jurkovitz et al (Jurkovitz, 
Franch, Shoham, Bellenger & McClellan, 2002). Thus, it is justified that there is not only an active search for 
these individuals but also proposals for their early care. 
Therefore, this study aimed to estimate the prevalence and socioeconomic characteristics of CKD in first 
and second-degree relatives of patients on hemodialysis. 
 
2.1 METHODS 
This is a cross-sectional study carried out with first and second-degree relatives of patients with CKD 
undergoing hemodialysis in three reference services in the municipalities of Açailândia and Imperatriz, southern 
Maranhão. Data were collected from September 2017 to March 2018 by direct invitation through hemodialysis 
patients or by publicizing the study in each clinic. 
This study occurred in two stages. In the first stage, CKD screening was performed in first and second-
degree relatives of patients on hemodialysis, and individuals diagnosed as having CKD were invited to return to 
participate in a reassessment of their clinical status after three months. 
To calculate the sample size, it was used the STATA 13.0 software (Stata Corp College Station, Texas, 
USA) and the significance level (α) of 5%, test power of 80%, a tolerable error of 4 %, plus 10% of possible 
losses in first and second-degree relatives of patients undergoing hemodialysis with an estimated prevalence of 
595 people per million inhabitants in Brazil. For this study, a convenience sample was used, totaling 408 
respondents. 
Inclusion criteria were age ≥ 18 years, both sexes, and first or second-degree relatives of patients with CKD 
who were on hemodialysis for more than three months. 
An adapted questionnaire from the PREVINA-SE (Kirsztajn & Bastos, 2015) study and the Screening for 
Occult Renal Disease (SCORED) study, which has already been validated for Brazil, was applied (Magacho et 
al., 2012) Data on socioeconomic, anthropometric, and clinical aspects, life habits, and CKD personal and family 
history were collected (Malachias et al., 2016). 
Subsequently, blood pressure, height, and weight were measured. The blood was collected after a minimum 
fasting of 10 hours to measure blood glucose, urea, and creatinine. Participants were instructed to bring a sample 
of the first-morning urine, which was not collected in case of infection, fever, or menstrual period. CKD was 
defined with an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73 m2 and/or the presence of a 
protein greater than 1 + in the urine sample (Romão, 2004). The following formula was used: CKD-EPI 
[(eGFR= 141 x min (Cr/κ, 1)α x max (Cr/κ, 1)-1,209 x 0.993age x 1,018 (if woman) x 1,159 (if Afro-American)). 
In the second phase of the study, individuals with CKD repeated urea and creatinine when eGFR ≤ 60 
mL/min /1.73 m2 or 24-hour proteinuria for patients with ≥ 1 + protein in the first-morning urine sample. 
As mentioned, the data were analyzed using the STATA 14.0 software (Stata Corp., College Station, Texas, 
USA). Descriptive statistics included the calculation of absolute, relative frequencies, mean, and standard 
deviation. The association between the explanatory variable and the response variable was performed using the 
Chi-square test. Logistic regression analysis was also performed to verify the association of events, the odds 
ratio (Odds ratio, OR) was used. The variables that presented p ≤ 0.20 were considered for the multivariate 
analysis employing multiple logistic regression, considering the hierarchy. Variables with p ≤ 0.10 were 
maintained in the hierarchical model for the control of residual confusion of variables. The 95% confidence 
intervals (95% CI) and level of statistical significance (p≤ 0.05) were considered. 
This study was approved by the Research Ethics Committee of CEUMA University (nº 1.055.539). All 
participants signed the Free and Informed Consent Form (ICF). 
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408 relatives of chronic kidney patients undergoing hemodialysis were studied, with a mean age of 39 years (± 
14.22), of whom 259 (63.5%) were women, 224 children (54.9%), and 128 (31.3 %) brothers. Regarding race, 
the majority referred to themselves as brown (68.87%). Regarding family income, 167 (40.9%) belonged to class 
D / E and 153 (37.5%) were illiterate / incomplete elementary II. The diagnosis of CKD was made in 49 (12%) 
participants, of which 27 (55.10%) had GFR ≤ 60 ml/min /1.72 m2 and 22 (44.89%) had proteinuria ≥ 1 + on 
examination morning urine (Table 1). 
The practice of physical activity and smoking were also questioned. Of the participants, 146 (35.78%) 
reported practicing some physical activity, of which 15 (30.61%) were diagnosed with CKD. 38 (9.31%) 
individuals reported smoking, of these three (6.12%) had CKD. When the chi-square test was applied, there was 
an association between CKD and kinship (p <0.001) and age (p <0.001) (Table 1). 
Regarding previous knowledge about CKD and hemodialysis, 280 (68.6%) had no knowledge about CKD, 
and 214 (52.45%) did not know about hemodialysis. The association of both knowledge of kidney disease and 
HD with the presence of CKD was tested using the chi-square test, with no significant association (p = 0.65 and 
p = 0.19, respectively) (Table 2). 
Regarding diabetes and hypertension, all responses were self-reported. Of the 359 participants without 
kidney disease, 20 (5.57%) reported diabetes and only 15 (4.18%) were being treated. In the group diagnosed 
with CKD, 07 (14.29%) participants declared themselves diabetic and under treatment. Regarding hypertension, 
57 (15.88%) claimed to be hypertensive, of which 49 (13.65%) were being treated. In the CKD group, 15 
(30.61%) reported arterial hypertension, of whom 13 (26.53%) underwent treatment (Table 2). 
Systolic Blood Pressure (SBP) was found to be above normal values (> 140 mmHg) in 50 (12.25%) 
participants, of whom 34 (8.33%) previously declared to be hypertensive. The mean SBP was 119 mmHg (± 
16.22). Regarding the Diastolic Blood Pressure (DBP), 81 (19.85%) were above normal (> 90 mmHg), of 39 
(9.55%) self-declared hypertensive. The mean DBP was 79.64 mmHg (± 10, 2). Among participants diagnosed 
with CKD, the mean SBP was 127 mmHg (± 22.31) and the DBP was 83 mmHg (± 12, 2) (Table 3). 
There were 72 (17.6%) people with blood glucose between 100-126 mg/dl, of whom six (1.47%) were 
already diabetic, 39 (9.56%) had blood glucose levels above 126.0 mg/dl and 20 (4.90%) were diagnosed with 
diabetes during the study. Among self-reported diabetics, 19 (48.71%) had higher levels considered above 
clinical control by the Brazilian Diabetes Society (SBD) (> 130.0 mg/dl). The average blood glucose level was 
95.58 mg/dl (± 43.15) in participants without CKD and 109.6 mg/dl (± 34.5) in patients diagnosed with CKD 
(Table 3). 
In the group without CKD, 134 (33.17%) were overweight and 98 (24.26%) were obese. The average body 
mass index (BMI) in participants without CKD was 26.6 kg/m2 (± 5.1). In the CKD group, the average was 28.0 
kg/m2 (± 4.38) (Table 3). 
There was an association with the variable age (OR: 1.60; 95% CI: 1.31-1.96; p <0.01), SBP (OR: 1.69; 
95% CI: 1.24-2, 28; p <0.001), DBP (OR: 1.52; 95% CI: 1.18-1.96; p <0.001) and blood sugar level (OR: 2.03; 
95% CI: 1.38-2, 99, p <0.001) and CKD (Table 4). 
CKD was classified into five stages according to the criteria adopted by K/DOQI (2002). It was found 21 
(42.85%) in stage 3A and 10.20% in 3B (Table 5). 
After three months, participants with CKD were reassessed, except for eight (16.32%) individuals due to 
refusal or change of address (city), as shown in Table 6. 
 
4.1 DISCUSSION 
The prevalence of CKD found in the first phase of this study was comparable to most of those that have already 
been executed, even with the average age (39 years) lower than those performed using the KEEP profile, such as 
KEEP Japan, in which the average age was 59.7 years, with age being a well-established risk factor for CKD 
(Takahashi, Okada & Yanai, 2010; Obrador et al., 2010; Brown et al., 2003). After the reassessment in three 
months, we had a 38.75% decrease from the initial value. As in the study by Afolabi, Abioye-Kuteyi, 
Arogundade & Bello (2009) the group diagnosed with CKD by the proteinuria criterion was the one that showed 
the greatest return to normal parameters. This fact corroborates the need for reassessment of these individuals 
and questions the real prevalence of CKD, especially in studies that used proteinuria as the only criterion and 
without reassessment. When compared with studies carried out in Brazil, a higher prevalence was observed, such 
as that found by Passos et al. (2003). According to our knowledge, only Bastos et al. (2009) reassessed the 
interviewees after three months, obtaining a smaller decrease in prevalence (from 12.4% to 9.6%). However, a 
minority of research carried out in Brazil adopts both proteinuria and GFR and a reassessment in three months 
for the diagnosis of CKD, as carried out in this study. 
When individuals were stratified according to the degree of renal dysfunction, values similar to those 
reported by most international studies were obtained, with a predominance of stage 3, as occurred in the 
American KEEP study (stage 1: 21%; stage 2: 19%; stage 3: 33% and stage 5: 3%) (Brown et al., 2003) This 
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allows intervening in the natural evolution of the disease and can preserve kidney function if this diagnosis is 
made early. In Brazil, few studies have stratified participants, among which the one with the largest number of 
individuals was ELSA-Brasil, finding 1.5% in stage 1, 2.6% in stage 2, 4.0% in stage 3, 0.6% in stage 3b, 0.2% 
in stage 4 and 0.1% in stage 5 (Barreto et al., 2016). As in the present study, there was no predominance of 
participants in stage 3 of CKD. 
Although there is no justification in the literature, it is observed that there is a higher prevalence of CKD in 
women (Obrador et al., 2010; Lima, Kesrouani, Gomes, Cruz & Mastroianni-Kirsztajn, 2012), including in the 
studies conducted by Freedman, Soucie & McClellan (1997) and Wei et al. (2012) who evaluated relatives of 
patients with kidney disease. In this study, even without obtaining statistical significance between the sexes, it 
was observed that the majority of participants with CKD were women, especially in more advanced stages, but it 
was not possible to determine a cause/effect relationship. 
Risk factors already established, such as hypertension and diabetes, behaved similarly to worldwide studies, 
demonstrating that relatives of kidney patients have several associated risk factors. In the NHANES studies 
1988-1994 and 1999-2002 and in the KEEP studies Mexico, Japan, and the USA, this association was well 
established (Takahashi, Okada & Yanai, 2010; Obrador et al., 2010; Brown et al., 2003; NHANES 2013-2014, 
2013). In the present study, the values found for Systemic Arterial Hypertension (46.93%) and diabetes (26.52%) 
were similar to those found by Bastos et al. (2009) corroborating its importance for CKD. These pathologies 
have been associated with CKD. It seems reasonable to think that families that have individuals who have lost 
kidney function due to these pathologies are more likely to develop CKD. 
Other “new” risk factors such as obesity and smoking have been associated with CKD, but it was not 
possible to establish this association, probably due to the low percentage of obese and smokers in this sample 
(25.92 and 3.7% respectively) which are in opposition to what was reported in the KEEP USA (44 and 45%, 
respectively) (Passos et al., 2003). The values in the present study were closer to those reported in a survey 
conducted in Egypt that also did not observe any association of these factors with CKD (Gouda et al., 2011). On 
the other hand, the regular practice of physical exercise has also not been shown to have a protective effect on 
CKD in this sample. 
CKD has a worldwide distribution; however, it is important to remember that in countries with an economic 
profile similar to Brazil, the lower economic and educational classes are the most affected, either due to lack of 
access to the health or information system (Brown et al., 2003). In the present study, most participants diagnosed 
with CKD had lower levels of education (63.26%) and social class (75.51%). When asked about the knowledge 
that this population had about CKD and hemodialysis and there is a high prevalence of non-knowledge about 
CKD (68.62%) and hemodialysis (52.45%) in the same way as the results found by Khalil and Abdalrahim (2014) 
in which about half of the study participants had no information about the pathology. Even though it is not 
possible to demonstrate statistical significance for these variables, it is believed that the greater clarification 
about CKD, can contribute positively so that a greater number of relatives of chronic renal patients seek to assess 
their renal health early. 
 
5.1 CONCLUSION 
It is clear that there is still a long way to go before the real prevalence of CKD is precisely known, especially in 
Brazil. 
The methodology used in this study was based on the use of the criteria established for the correct diagnosis 
and staging of CKD, accepted internationally, with results similar to those already published in the literature, 
confirming the need for public health measures aimed at the early diagnosis of CKD in Brazil. 
The relatives of patients with CKD are at risk, and unlike hypertensive and diabetic patients who have 
specific health policies, they go unnoticed even in hemodialysis clinics, where they often take their relatives for 
dialysis. There are findings of several participants with relevant renal dysfunction, including stage 5, which 
justifies the implementation of simple routines, especially in hemodialysis clinics, to identify and clinically 
measure this population early. 
CKD is a silent pathology for patients and doctors. It has high costs for the health system and the quality of 
life of the patient and his family. "Any" gain in time without dialysis justifies the creation of simple routines to 
identify CKD early. 
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Table 1. Sociodemographic, epidemiological and clinical characteristics of 408 relatives diagnosed or not with 
chronic kidney disease. 
Variable 
eGFR-EPI + Proteinuria 
p-value 
With CKD n (%) Without CKD n (%) 
Relationship   0.01 
Brother / sister 12 (24.49) 116 (32.31)  
Father / mother 12 (24.49) 27 (7.52)  
Son / daughter 21 (42.86) 203(56.55)  
Grandchildren 4 (8.16) 12 (3.34)  
Cousins 0 (0.00) 1 (0.27)  
Gender   0.54 
Female  33 (67.35) 226 (62.95)  
Male 16(32.65) 133 (37.05)  
Race   0.48 
Brown 36 (73.47) 245 (68.25)  
White 8 (16.33) 53 (14.76)  
Black 5 (10.20) 61 (16.99)  
Age group   < 0.01 
18-29 years 8 (16.33) 109 (30.36)  
30-39 years 14 (28.57) 109 (30.36)  
40-49 years 3 (6.12) 69 (19.22)  
50-59 years 6 (12.24) 45 (12.53)  
60-69 years 9 (18.37) 20 (5.57)  
> 70 years 9 (18.37) 7 (1.95)  
Social-economic class   0.58 
A 0 (0.00) 1 (0.28)  
B1 1 (2.04) 4 (1.11)  
B2 0 (0.00) 16 (4.46)  
C1 9 (18.37) 72 (20.06)  
C2 15 (30.61) 123 (34.26)  
D/E 24 (48.98) 143 (39.83)  
Education level   0.24 
Illiterate / incomplete elementary II 24 (48.98) 129 (35.93)  
Complete elementary II / incomplete high-school 7 (14.29) 67 (18.66)  
Complete high-school / incomplete higher 
education 
17 (34.69) 138 (38.44)  
Complete higher education 1 (2.04) 25 (6.96)  
Practice of physical exercise   0.42 
Yes 15(30.61) 131(36.49)  
No 34 (69.39) 228 (63.51)  
Smoking   0.41 
Yes 3 (6.12) 35 (9.75)  
No 46 (93.88) 324(90.25)  
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Table 2. Results on knowledge of CKD and hemodialysis and pathological antecedents (hypertension and 
diabetes) in patients with and without chronic kidney disease. 
Variable 
eGFR-EPI + Proteinuria p-value 
With CKD n (%) Without CKD n (%)  
Knows CKD   0.65 
Yes 14 (28.57) 114 (31.75)  
No 35 (71.43) 245 (68.25)  
Knows Hemodialysis   0.19 
Yes 19 (38.78) 175 (48.75)  
No 30 (61.22) 184 (51.25)  
Diabetes   0.03 
Yes 7 (14.29) 20 (5.57)  
No 38 (77.55) 322 (89.69)  
Does not know 4 (8.16) 17 (4.74)  
Treats diabetes   0.03 
Yes 7 (14.29) 15 (4.18)  
No 42 (85.71) 344 (95.82)  
Hypertension   0.04 
Yes 15 (30.61) 57 (15.88)  
No 33 (67.35) 292 (81.34)  
Does not know 1 (2.04) 10 (2.79)  
Treats hypertension   0.01 
Yes  13 (26.53) 49 (13.65)  
No 36 (73.47) 310 (86.35)  
 
Table 4. Logistic regression of variables commonly associated with CKD: age, kinship, diabetes, blood glucose, 
hypertension, SBP, DBP, and whether knows hemodialysis. 
Variable Odds-ratio (OR) Confidence interval P-value 
Age 1.60 0.00 – 1.31 < 0.001 
Kinship 1.03 0.75 – 1.41 0.82 
Diabetes 1.64 0.04 – 1.01 < 0.05 
Hypertension 1.62 0.95 – 2.78 < 0.05 
SBP 1.69 1.24 – 2.28 <0.001 
DBP 1.52 1.18 – 1.96 <0.001 
Glycemia 2.03 1.38 – 2.99 <0.001 
Knows HD 0.66 0.36 – 1.22 0.1 
SBP: systolic blood pressure; DBP: diastolic blood pressure; CKD: chronic kidney disease; HD: hemodialysis 
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Table 5. Characteristics of socioeconomic variables of participants diagnosed with chronic kidney disease. 
Variable Stage 1 Stage 2 Stage 3a Stage 3b Stage 5 
n = 49 11 (22.44) 11 (22.44) 21 (42.85) 05 (10.20) 01 (2.04) 
Average age 31.72 37.45 60.14 64.40 49.00 
Kinship      
Brothers - 03 (27.27) 01 (4.76) 01 (20.00) 01 (100.00) 
Parents - 01 (9.09) 7 (33.33) 03 (60.00) - 
Children 11 (100.00) 05 (45.45) 8 (38.10) - - 
Grandchildren - 02 (18.18) 4 (19.05) 01 (20.00) - 
Cousins - - 01 (4.76) - - 
Gender      
Male 03 (27.27) 06 (54.54) 05 (23.81) 02 (40.00) - 
Female 08 (72.72) 05 (45.45) 16 (76.19) 03 (60.00) 01 (100.00) 
Race      
Brown 07 (63.63) 09 (81.81) 16 (76.19) 04 (80.00) - 
White 01 (9.09) 02 (18.18) 4 (19.05) - 01 (100.00) 
Knowledge on CKD/HD      
Knows CKD 06 (54.54) 05 (45.45) 03 (27.27) 0.0 (0.00) - 
Knows HD 05 (45.45) 07 (63.63) 06 (54.54) 01 (20.00) - 
Economy class      
B1 01 (9.09) - - - 01 (100.00) 
B2 - - - - - 
C1 02 (18.18) 02 (18.18) 04 (19.05) 01 (20.00) - 
C2 06 (54.54) 04 (36.36) 04 (19.05) 01 (20.00) - 
D/E 02 (18.18) 05 (45.45) 13 (61.90) 03 (60.00) 01 (100.00) 
Education level      
Illiterate / Incomplete elementary 02 (18.18) 04 (36.36) 14 (66.67) 04 (80.00) - 
Complete elementary / incomplete 
high-school 
02 (18.18) 03 (27.27) 01 (4.76) - 01 (20.00) 
Complete high-school / incomplete 
higher education 
06 (54.54) 04 (36.36) 06 (28.57) - - 
Complete higher education 01 (9.09) - - 01 (20.00) - 
Smoking      
 01 (9.09) 01 (4.76) 00 (0.00) 0.0 (0.00) 01 (9.09) 
Physical exercise      
 03 (27.27) 04 (36.36) 07 (33.33) 01 (20.00) 0.0 (0.00) 
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Systolic Blood Pressure      
Normal 07 (63.63) 07 (63.63) 07 (33.33) - 01 (100.00) 
Pre-hypertension 04 (36.36) 03 (27.27) 07 (33.33) 01 (20.00) - 
Systolic hypertension stage 1 - 01 (9.09) 04 (19.05) 03 (60.00) - 
Systolic hypertension stage 2 - - 01 (4.76) 01 (20.00) - 
Systolic hypertension stage 3 - - 02 (9.52) - - 
Diastolic Blood Pressure      
Normal 10 (90.90) 06 (54.54) 09 (42.85) 01 (20.00) 01 (100.00) 
Pre-hypertension 01 (9.09) - 04 (19.05) 03 (60.00) - 
Diastolic hypertension stage 1 - 04 (36.36) 03 (14.28) - - 
Diastolic hypertension stage 2 - 01 (9.09) 03 (14.28) 01 (20.00) - 
Diastolic hypertension stage 3 - - 02 (9.52) - - 
Body Mass Index (BMI)      
Low weight 01 (9.09) - - - - 
Normal weight 04 (36.36) 01 (9.09) 07 (33.33) 01 (20.00) 01 (100.00) 
Overweight 05 (45.45) 05 (45.45) 09 (42.86) 02 (40.00) - 
Obesity 1 01 (9.09) 04 (36.36) 04 (19.05) 02 (4000) - 
Obesity 2 - 01 (9.09) - - - 
Obesity 3 - - 01 (4.76) - - 
Glycaemia      
Normal 07 (63.63) 06 (54.54) 08 (38.09) 02 (40.00) 01 (100.00) 
Changed fasting glycaemia 01 (9.09) 02 (18.18) 09 (42.85) - - 
Diabetes 01 (9.09) 03 (27.27) 04 (19.05) 03 (60.00) - 
 
 
 
